Results 101 to 110 of about 89,895 (292)
Evidence for separate disease phenotypes in intestinal Crohn's disease [PDF]
N R Borley +5 more
openalex +1 more source
Abstract Objectives There are no standardized criteria about stepping down from combination therapy (immunomodulator and tumor necrosis factor (TNF)‐alpha‐inhibitors) in children with inflammatory bowel disease (IBD) to reduce risk for side effects. Our aim was to describe how de‐escalation has been performed in a large pediatric cohort and to find ...
Sila Cekin +5 more
wiley +1 more source
Treatment of pyoderma gangrenosum (PG) complicating Crohn's disease (CD) with infliximab
John J. Hong +2 more
openalex +1 more source
Abstract Objective Fatigue is highly prevalent in children with inflammatory bowel disease (IBD), even during clinical remission. This suggests a role for transdiagnostic factors—lifestyle, psychological, and social influences not specific to the disease.
Maartje D. Stutvoet +6 more
wiley +1 more source
Abstract Objectives Deficiency of serum 25‐hydroxyvitamin D [25(OH)D] was associated with decreased short‐term response to anti‐tumor necrosis factor‐alpha (TNF‐α) agents in adults with inflammatory bowel disease (IBD). The aim of this study was to evaluate the association between serum 25(OH)D levels and the outcome of children with IBD undergoing ...
Adi Anafy +6 more
wiley +1 more source
INFLUENCE OF THE TYPE OF MANIFESTATION OF CROHN'S DISEASE ON THE CORRELATION BETWEEN CLINICAL, ENDOSCOPIC, AND HISTOLOGICAL INDICES [PDF]
Paula Fernandes de Sousa +2 more
openalex +1 more source
Abstract Objectives Pediatric patients with chronic gastrointestinal (GI) conditions including inflammatory bowel diseases (IBD) and irritable bowel syndrome (IBS) on average endorse lower health related quality of life (HRQOL) than their healthy counterparts.
S. Taylor Younginer +6 more
wiley +1 more source
Crohn's disease-associated keratopathy: A case report
Purpose: This study reports a case of Crohn's disease-associated keratopathy that progressed with disease activity. Observations: A 29-year-old man diagnosed with Crohn's disease and receiving systemic adalimumab therapy, presented with an irregular ...
Ji Ho Kim +3 more
doaj +1 more source

